13 Jun 2019 EuroPneumo 2019 (Germany)
Shannon David and Zoe Laan give presentations at the 14th European Meeting on the Molecular Biology of the Pneumococcus in Greifswald, Germany...
News
22 May 2019 GPN Vaccines’ Chairman & CEO receives accolade
Tim Hirst named one of Australia’s top 50 small business leaders 2019 [https://insidesmallbusiness.com.au/planning-management/australias-top-50-small-business-leaders-2019]...
21 May 2019 Publication in Nature Microbiology
Publication in Nature Microbiology shows Gamma-PN boosts the immune systems’ response to flu vaccination [21 May 2019 Press Release]...
03 May 2019 Publication in Immunology & Cell Biology
Publication in ICB of a study on GPN Vaccines' killed whole-cell pneumococcal vaccine [https://doi.org/10.1111/imcb.12257]...
17 Apr 2019 World Vaccine Congress (USA)
GPN Vaccines’ Chairman & CEO gives presentation on “A new serotype-independent pneumococcal vaccine” at the World Vaccine Congress (USA) in Washington DC....
22 Feb 2019 Professor Helen Marshall joins GPN Vaccines’ Scientific & Advisory Board
Prof Marshall has been an investigator on more than 50 clinical trials including studies on influenza, pertussis, meningococcal and human Papillomavirus vaccines. [Press Release]...